4.6 Article

Activation of NF-kappa B1 by OX40 contributes to antigen-driven T cell expansion and survival

Journal

JOURNAL OF IMMUNOLOGY
Volume 180, Issue 11, Pages 7240-7248

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.11.7240

Keywords

-

Categories

Funding

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049453, P01AI050498] Funding Source: NIH RePORTER
  2. NIAID NIH HHS [AI49453, R01 AI049453-02, R01 AI049453-04, R01 AI049453, P01 AI050498, R01 AI049453-05, P01 AI050498-010001, R01 AI049453-06, R01 AI049453-01A2, R01 AI049453-03, AI50498, P01 AI050498-020001] Funding Source: Medline

Ask authors/readers for more resources

The costimulatory molecule OX40 (CD134) is required in many instances for effective T cell-mediated immunity, controlling proliferation, and survival of T cells after encountering specific Ag. We previously found that the functional targets of OX40 are survivin and aurora B that regulate proliferation and Bcl-2 antiapoptotic family members that regulate survival. However, the intracellular pathways from OX40 that mediate these effects are unclear. In this study, we show that OX40 signaling can target the canonical NF-kappa B (NF-kappa B1) pathway in peripheral Ag-responding CD4 T cells. Phosphorylation of I kappa B alpha, nuclear translocation of NF-kappa B1/p50 and RelA, and NF-kappa B1 activity, are impaired in OX40-deficient T cells. Retroviral transduction of active I kappa B kinase that constitutively activates NF-kappa B1 rescues the poor expansion and survival of OX40-deficient T cells, directly correlating with increased expression and activity of survivin, aurora B, and Bcl-2 family members. Moreover, active licB kinase expression alone is sufficient to restore the defective expansion and survival of OX40-deficient T cells in vivo when responding to Ag. Thus, OX40 signals regulate T cell number and viability through the NF-kappa B1 pathway that controls expression and activity of intracellular targets for proliferation and survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available